Patents by Inventor Francesca Cavazza

Francesca Cavazza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED HYALURONIC ACID DERIVATIVES AND USE THEREOF
    Publication number: 20150252120
    Abstract: The present invention relates to hyaluronic acid derivative of Formula I, their synthesis and use thereof as cosmetics or as medicaments in a subject in need.
    Type: Application
    Filed: October 7, 2013
    Publication date: September 10, 2015
    Inventors: Antonino Di Pietro, Francesca Cavazza, Paolo Caliceti
  • Therapeutical method for the treatment of the Leber optic neuropathy
    Patent number: 9114120
    Abstract: It is described the use of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, for the preparation of a medicament or a nutritional supplement useful for preventing or treating the Leber optic neuropathy.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: August 25, 2015
    Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P.A.
    Inventors: Aleardo Koverech, Stefania D'Iddio, Anna Atti, Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza
  • THERAPEUTICAL METHOD FOR THE TREATMENT OF THE LEBER OPTIC NEUROPATHY
    Publication number: 20140051757
    Abstract: It is described the use of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, for the preparation of a medicament or a nutritional supplement useful for preventing or treating the Leber optic neuropathy.
    Type: Application
    Filed: September 9, 2011
    Publication date: February 20, 2014
    Applicant: SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Silvia Cavazza, Martina Cavazza, Francesca Cavazza, Anna Atti, Enrico Cavazza
  • COMBINATION COMPOSITION USEFUL FOR TREATING CARDIOVASCULAR DISEASES
    Publication number: 20130236551
    Abstract: It is described the use of a combination consisting of a microcapsule suspension comprising one or more statins in alkyl esters of n-3 PUFA in which the statins are isolated from contact with the alkyl ester of n-3 PUFA by means of a polymeric membrane that can be easily disintegrated in the gastrointestinal medium, for the treatment of cardiovascular diseases.
    Type: Application
    Filed: November 30, 2010
    Publication date: September 12, 2013
    Applicant: DEFIANTE FARMACEUTICA .S.A.
    Inventors: Anna Atti, Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta
  • TREATMENT OF ONCOLOGICAL DISEASES
    Publication number: 20120208883
    Abstract: The present invention relates to the use of acetyl L-carnitine for the preparation of a medicament for the prevention and/or treatment of cancer. Methods of preventing and/or treatment of cancer by administering an effective amount of acetyl L-carnitine to subject in need thereof are also disclosed.
    Type: Application
    Filed: December 1, 2009
    Publication date: August 16, 2012
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A
    Inventors: Claudio Cavazza, Anna Atti, Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza, Paolo Carminati, Gabriella Singrossi, Silvia Carminati, Giuseppe Paolo Carminati, Claudio Pisano